Related Experiment Video
Updated: Aug 8, 2026
07:13
Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity
Published on: January 6, 2015
Pulmonary emphysema and alpha 1-antitrypsin deficiency
British Medical Journal
|March 27, 1971
Summary
Pulmonary emphysema patients often have alpha(1)-antitrypsin deficiency, a condition causing early-onset breathlessness and lung function decline. Smoking may accelerate emphysema development in these individuals.
Area of Science:
- Pulmonary Medicine
- Genetics
- Respiratory Diseases
Background:
- Pulmonary emphysema is a significant respiratory condition.
- Alpha(1)-antitrypsin deficiency is a genetic disorder that can lead to lung disease.
- Identifying risk factors and early indicators of emphysema is crucial for patient outcomes.
Purpose of the Study:
- To investigate the prevalence of alpha(1)-antitrypsin deficiency in patients with radiological evidence of pulmonary emphysema.
- To characterize the clinical and radiological features associated with alpha(1)-antitrypsin deficiency in emphysema patients.
- To explore potential contributing factors, such as smoking, in the development of this condition.
Main Methods:
- Retrospective analysis of 72 patients diagnosed with pulmonary emphysema.
- Assessment of clinical symptoms, including exertional dyspnea and age of onset.
- Evaluation of pulmonary function tests, specifically FEV(1) and T(L)CO.
- Radiological examination to identify emphysema distribution, particularly in the lower lung zones.
Main Results:
- Out of 72 patients with emphysema, 61 had emphysema alone or with bronchitis.
- Alpha(1)-antitrypsin deficiency was identified in 8 of these patients (13%).
- Key features in deficient patients included early-onset exertional dyspnea (30-45 years), severely impaired FEV(1) and T(L)CO, and lower-zone predominant emphysema.
Conclusions:
- Alpha(1)-antitrypsin deficiency is a notable comorbidity in patients with pulmonary emphysema.
- A combination of early dyspnea, reduced lung function, and lower-zone emphysema strongly suggests alpha(1)-antitrypsin deficiency.
- Cigarette smoking appears to be a potential factor that exacerbates the onset of emphysema in individuals with alpha(1)-antitrypsin deficiency.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...